| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/22/2002 | CN1350533A New ECE inhibitors, their production and their use |
| 05/22/2002 | CN1350530A 酰胺衍生物 Amide derivatives |
| 05/22/2002 | CN1350529A Solvates of pymetrozine |
| 05/22/2002 | CN1350528A 4,5,6,7-tetrahydroindazole derivatives as antitumor agents |
| 05/22/2002 | CN1350527A Aminomethylpyrrolidine derivatives having aromatic substituents |
| 05/22/2002 | CN1350524A Quinoline derivatives as inhibitors of MEK enzymes |
| 05/22/2002 | CN1350523A Indoline derivatives as progesterohe antagonists |
| 05/22/2002 | CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 05/22/2002 | CN1350458A Protease inhibitors |
| 05/22/2002 | CN1349989A 4-hydroxyl-piperidine derivative |
| 05/22/2002 | CN1349796A Pyrrole derivatives and medicine composition |
| 05/21/2002 | US6392067 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors |
| 05/21/2002 | US6391910 Opioid antagonist; analgesic |
| 05/21/2002 | US6391907 Anticancer agents; contraceptives |
| 05/21/2002 | US6391896 3-Tetrahydropyridin-4-yl indoles for treatment of psychotic disorders |
| 05/21/2002 | US6391891 Bicyclic compounds as ligands for 5-HT1 receptors |
| 05/21/2002 | US6391889 Potent antimicrobial activity on broad range of microorganisms, e.g., staphylococcus, grampositive bacteria and quinolone antibiotic resistance; side effect reduction; nontoxic |
| 05/21/2002 | US6391883 Bicyclic amines |
| 05/21/2002 | US6391882 4,5,6 and 7-indole and indoline derivatitives, their preparation and use |
| 05/21/2002 | US6391880 Anticholesterol agents |
| 05/21/2002 | US6391874 Anticarcinogenic agents; skin disorders |
| 05/21/2002 | US6391865 Aids therapy; antiinflammatory agents; rheumatic diseases; skin disorders |
| 05/21/2002 | US6391827 Pyrrolic compounds having a high herbicidal activity and their agronomic use |
| 05/21/2002 | US6391064 Composition for hair dyeing comprising condensates of quinoline-5, 8-diones or of quinoxaline-5,8-diones and substituted pyrroles, anilines or indoles |
| 05/21/2002 | CA2216664C New n-substituted cyclical amines, their preparation process and the pharmaceutical compositions containing them |
| 05/21/2002 | CA2148595C Molecule labelling using 2-hydrazinopyridine derivatives |
| 05/21/2002 | CA2134077C 4-imidomethyl-1-¬2'phenyl-2'oxoethyl-|piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy |
| 05/16/2002 | WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 05/16/2002 | WO2002038560A1 Carbamate derivatives, process for producing the same and use thereof |
| 05/16/2002 | WO2002038559A1 1,3-diazaheterocyclic compounds and their use as oral hypoglycaemic agents |
| 05/16/2002 | WO2002038553A2 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists |
| 05/16/2002 | WO2002038551A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 05/16/2002 | WO2002038549A1 Hetero-anellated ortho-aminophenols and their use as dye components |
| 05/16/2002 | WO2002038547A1 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 05/16/2002 | WO2002038544A2 3-substituted oxindole beta 3 agonists |
| 05/16/2002 | WO2002038543A2 3-substituted oxindole beta 3 agonists |
| 05/16/2002 | WO2002038541A1 Cyanopyrrolidine derivatives |
| 05/16/2002 | WO2002038184A1 Oral pharmaceutical composition containing a block copolymer |
| 05/16/2002 | WO2002037937A2 Acid derivatives useful as serine protease inhibitors |
| 05/16/2002 | WO2002030891A8 Aliphatic nitrogenous five-membered ring compounds |
| 05/16/2002 | WO2002030890A8 Nitrogenous five-membered ring compounds |
| 05/16/2002 | WO2002020488A3 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor |
| 05/16/2002 | WO2002019994A3 The treatment of inflammatory disorders |
| 05/16/2002 | WO2002018339A3 Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same |
| 05/16/2002 | WO2002010158A3 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 05/16/2002 | WO2001096295A3 2-cyanopyrrolidine derivatives and their use as medicaments |
| 05/16/2002 | WO2001092228A3 Process for the synthesis of amine ethers from secondary amino oxides |
| 05/16/2002 | WO2001087287A3 Use of pyrazole derivatives for treating infertility |
| 05/16/2002 | WO2001083478A3 Hydantoin-containing glucokinase activators |
| 05/16/2002 | WO2001083465A3 Alkynyl phenyl heteroaromatic glucokinase activators |
| 05/16/2002 | WO2001079198A9 Pyrazoles for inhibiting protein kinase |
| 05/16/2002 | WO2001079195A3 Pyridine and pyrazine derivatives as thrombin inhibitors |
| 05/16/2002 | WO2001062946A8 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds |
| 05/16/2002 | US20020058816 For therapy of eating disorder, obesity, bulimia nervosa, diabetes, binge eating, anorexia nervosa, dyslipidimia, hypertension, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/ reproductive disorders, depression |
| 05/16/2002 | US20020058813 Spiro-indolines as Y5 receptor antagonists |
| 05/16/2002 | US20020058811 Naphthalene derivatives |
| 05/16/2002 | US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis |
| 05/16/2002 | US20020058681 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 05/16/2002 | US20020058678 For therapy of diseases or pathological conditions involving inflammation such as chronic inflammatory diseases |
| 05/16/2002 | US20020058677 Isoquinolone inhibitors of factor Xa |
| 05/16/2002 | US20020058665 For use in cancer therapy |
| 05/16/2002 | US20020058664 Beta-amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4 |
| 05/16/2002 | US20020058662 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 05/16/2002 | US20020058657 2-[1H]-quinolone and 2-[1H]-quinoxalone inhibitors of factor Xa |
| 05/16/2002 | US20020058653 Administering cyclic polyamine compound to elevate white blood cell (WBC) count |
| 05/16/2002 | US20020058652 Pharmaceutical compositions and methods for use |
| 05/16/2002 | US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 05/16/2002 | US20020058244 Detecting modulators of pyrmidine biosynthesis; obtain plant, expose to modulator, compare to control, monitor adjustment in pyrimidine biosynthesis |
| 05/16/2002 | DE10056312A1 New 1-(N-substituted amidoalkyl) bicyclic uracil derivatives useful as medicaments for treating ischemia or reperfusion damage, are poly-(ADP-ribose)-synthetase inhibitors |
| 05/16/2002 | CA2428784A1 Oral pharmaceutical composition containing a block copolymer |
| 05/16/2002 | CA2428123A1 Carbamate derivatives, their production and use |
| 05/16/2002 | CA2427350A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 05/16/2002 | CA2426716A1 Acid derivatives useful as serine protease inhibitors |
| 05/16/2002 | CA2421594A1 3-substituted oxindole beta 3 agonists |
| 05/16/2002 | CA2421154A1 Peroxisome proliferator activated receptor alpha agonists |
| 05/15/2002 | EP1205559A1 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating the drug effect of antimicrobial agent, and antimicrobial agents |
| 05/15/2002 | EP1205477A1 Mutual prodrug of amlodipine and atorvastatin |
| 05/15/2002 | EP1204668A1 Bisimidino compounds and the transitional metal complexes thereof as well as the use thereof as catalysts |
| 05/15/2002 | EP1204665A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204664A1 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204661A1 Derivatives of trifluoromethylpyri(mi)dine |
| 05/15/2002 | EP1204657A1 Piperidine and pyrrolidine derivatives displaying neuronal activity |
| 05/15/2002 | EP1204649A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/15/2002 | EP1204643A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 05/15/2002 | EP1204642A1 Fungicides |
| 05/15/2002 | EP1204640A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204323A1 Fungicides |
| 05/15/2002 | EP1204322A1 Fungicides |
| 05/15/2002 | EP0729460B1 Substituted 5-ring heterocycles, their preparation and their use |
| 05/15/2002 | CN1349527A Substituted benzolactam compounds |
| 05/15/2002 | CN1349526A Prodrugs of thrombin inhibitors |
| 05/15/2002 | CN1349525A Di-aryl acid derivatives as PPAR receptor ligands |
| 05/15/2002 | CN1349524A Renin inhibitors |
| 05/15/2002 | CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 05/15/2002 | CN1349510A Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 05/15/2002 | CN1349507A Pyridine-2,3-dicarboxylic acid diamides |
| 05/15/2002 | CN1349506A Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor |
| 05/15/2002 | CN1349504A Piperidine derivatives useful as CCR5 antagonists |